List of pharmaceutical and medicine manufacturing patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7964613 Sulfonamide compound	Patent 7964613 was granted and assigned to Asahi Kasei Pharma on June, 2011 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	7964613	June 21, 2011
‌ US Patent 8258269 Method for producing high-purity soluble thrombomodulin	Patent 8258269 was granted and assigned to Asahi Kasei Pharma on September, 2012 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	8258269	September 4, 2012
‌ US Patent 9809809 Neurotoxins exhibiting shortened biological activity	Patent 9809809 was granted and assigned to Merz Pharma on November, 2017 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	9809809	November 7, 2017
‌ US Patent 11357821 Recombinant clostridial neurotoxins with increased duration of effect	Patent 11357821 was granted and assigned to Merz Pharma on June, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11357821	June 14, 2022
‌ US Patent 7618984 Sulfonamide compound	Patent 7618984 was granted and assigned to Asahi Kasei Pharma on November, 2009 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	7618984	November 17, 2009
‌ US Patent 8415372 Sulfonamide compound	Patent 8415372 was granted and assigned to Asahi Kasei Pharma on April, 2013 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	8415372	April 9, 2013
‌ US Patent 9975929 Recombinant clostridial neurotoxins with increased duration of effect	Patent 9975929 was granted and assigned to Merz Pharma on May, 2018 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	9975929	May 22, 2018
‌ US Patent 11331434 Botulinum toxin prefilled syringe system	Patent 11331434 was granted and assigned to Merz Pharma on May, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11331434	May 17, 2022
‌ US Patent 9593098 Compounds and compositions for modulating EGFR mutant kinase activities	Patent 9593098 was granted and assigned to Yuhan on March, 2017 by the United States Patent and Trademark Office.	Yuhan	Yuhan	United States Patent and Trademark Office	9593098	March 14, 2017
‌ US Patent 9200804 Device for eliminating harmful substance	Patent 9200804 was granted and assigned to Bioneer on December, 2015 by the United States Patent and Trademark Office.		Bioneer	United States Patent and Trademark Office	9200804	December 1, 2015
‌ US Patent 10975411 Method and reagent for measuring mevalonic acid, 3-hydroxymethylglutaryl coenzyme A, and coenzyme A	Patent 10975411 was granted and assigned to Asahi Kasei Pharma on April, 2021 by the United States Patent and Trademark Office.	Asahi Kasei Pharma	Asahi Kasei Pharma	United States Patent and Trademark Office	10975411	April 13, 2021
‌ US Patent 8952137 Method for producing high-purity soluble thrombomodulin	Patent 8952137 was granted and assigned to Asahi Kasei Pharma on February, 2015 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	8952137	February 10, 2015
‌ US Patent 9458491 Method and reagent for measuring mevalonic acid, 3-hydroxymethylglutaryl coenzyme A, and coenzyme A	Patent 9458491 was granted and assigned to Asahi Kasei Pharma on October, 2016 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	9458491	October 4, 2016
‌ US Patent 11492335 Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same	Patent 11492335 was granted and assigned to Yuhan on November, 2022 by the United States Patent and Trademark Office.	Yuhan	Yuhan	United States Patent and Trademark Office	11492335	November 8, 2022
‌ US Patent 11497795 Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent	Patent 11497795 was granted and assigned to Asahi Kasei Pharma on November, 2022 by the United States Patent and Trademark Office.	Asahi Kasei Pharma	Asahi Kasei Pharma	United States Patent and Trademark Office	11497795	November 15, 2022
‌ US Patent 11545349 Matrix-assisted laser desorption/ionization mass spectrometry method	Patent 11545349 was granted and assigned to Bioneer on January, 2023 by the United States Patent and Trademark Office.	Bioneer	Bioneer	United States Patent and Trademark Office	11545349	January 3, 2023
‌ US Patent 10472665 Measuring method and composition using kinase	Patent 10472665 was granted and assigned to Asahi Kasei Pharma on November, 2019 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	10472665	November 12, 2019
‌ US Patent 10000791 Measurement method for human pancreatic lipase activity	Patent 10000791 was granted and assigned to Asahi Kasei Pharma on June, 2018 by the United States Patent and Trademark Office.	Asahi Kasei Pharma	Asahi Kasei Pharma	United States Patent and Trademark Office	10000791	June 19, 2018
‌ US Patent 6849404 Polymerase chain reaction of DNA of which base sequence is completely unidentified	Patent 6849404 was granted and assigned to Bioneer on February, 2005 by the United States Patent and Trademark Office.		Bioneer	United States Patent and Trademark Office	6849404	February 1, 2005
‌ US Patent 6867320 Substituted phenylalkanoic acid derivatives and use thereof	Patent 6867320 was granted and assigned to Asahi Kasei Pharma on March, 2005 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	6867320	March 15, 2005
‌ US Patent 10900063 Measurement of Lp-PLA	Patent 10900063 was granted and assigned to Asahi Kasei Pharma on January, 2021 by the United States Patent and Trademark Office.	Asahi Kasei Pharma	Asahi Kasei Pharma	United States Patent and Trademark Office	10900063	January 26, 2021
‌ US Patent 10562865 Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same	Patent 10562865 was granted and assigned to Yuhan on February, 2020 by the United States Patent and Trademark Office.	Yuhan	Yuhan	United States Patent and Trademark Office	10562865	February 18, 2020
‌ US Patent 11713308 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same	Patent 11713308 was granted and assigned to Yuhan on August, 2023 by the United States Patent and Trademark Office.	Yuhan	Yuhan	United States Patent and Trademark Office	11713308	August 1, 2023
‌ US Patent 7893050 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension	Patent 7893050 was granted and assigned to Asahi Kasei Pharma on February, 2011 by the United States Patent and Trademark Office.		Asahi Kasei Pharma	United States Patent and Trademark Office	7893050	February 22, 2011
‌ US Patent 9827298 Neurotoxins exhibiting shortened biological activity	Patent 9827298 was granted and assigned to Merz Pharma on November, 2017 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	9827298	November 28, 2017

...

Results per page:

226 results

0 selected

226 results

0 selected